Table 2.
Characterization of postdischarge persistent symptoms during the second and sixth weeks of follow-up.
| Symptoms | Week-2 follow-up | Week-6 follow-up | |||||||
|
|
Overall (N=120), n (%) | Non-ICUa patients (n=70), n (%) | ICU patients (n=50), n (%) |
P value |
Overall (N=120), n (%) | Non-ICU patients (n=70), n (%) | ICU patients (n=50), n (%) |
P value |
|
| Fatigue | 81 (67.5) | 44 (62.9) | 37 (74.0) | .12 | 67 (55.8) | 38 (54.3) | 29 (58.0) | .51 | |
| Dyspnea | 36 (30.0) | 17 (24.3) | 19 (38.0) | .11 | 24 (20.0) | 11 (15.7) | 13 (26.0) | .17 | |
| Anxiety/ depression | 10 (8.3) | 5 (7.1) | 5 (10.0) | .58 | 6 (5.0) | 3 (4.3) | 3 (6.0) | >.99 | |
| Fever | 2 (1.7) | 1 (1.4) | 1 (2.0) | .99 | 0 (0) | 0 (0) | 0 (0) | N/Ab | |
| Headache | 10 (8.3) | 5 (7.1) | 5 (10.0) | .58 | 3 (2.5) | 1 (1.4) | 2 (4.0) | .77 | |
| Cough | 25 (20.8) | 10 (14.3) | 15 (30.0) | .04 | 12 (10.0) | 5 (7.1) | 7 (14.0) | .22 | |
| Myalgia | 12 (10.0) | 6 (8.6) | 6 (12.0) | .54 | 6 (5.0) | 3 (4.3) | 3 (6.0) | >.99 | |
| Arthralgia | 11 (9.2) | 5 (7.1) | 6 (12.0) | .36 | 4 (3.3) | 2 (2.9) | 2 (4.0) | >.99 | |
| Chest pain | 2 (1.7) | 1 (1.4) | 1 (2.0) | .99 | 1 (0.8) | 0 (0) | 1 (2.0) | .87 | |
| Loose stools | 11 (9.2) | 6 (8.6) | 5 (10.0) | .79 | 4 (3.3) | 2 (2.9) | 2 (4.0) | >.99 | |
| Loss of appetite | 20 (16.7) | 9 (12.9) | 11 (22.0) | .19 | 13 (10.8) | 7 (10.0) | 6 (12.0) | .73 | |
| Weight loss | 23 (19.1) | 7 (10.0) | 16 (32.0) | .003 | 20 (16.7) | 13 (18.6) | 7 (14.0) | .22 | |
| Sleep disturbances | 21 (17.5) | 9 (12.9) | 12 (24.0) | .11 | 11 (9.2) | 5 (7.1) | 6 (12.0) | .36 | |
| Runny nose | 2 (1.7) | 1 (1.4) | 1 (2.0) | .99 | 0 (0) | 0 (0) | 0 (0) | N/A | |
| Loss of smell | 7 (5.8) | 4 (5.7) | 3 (6.0) | >.99 | 4 (3.3) | 2 (2.9) | 2 (4.0) | >.99 | |
| Loss of taste | 9 (7.5) | 5 (7.1) | 4 (8.0) | .99 | 4 (3.3) | 2 (2.9) | 2 (4%) | >.99 | |
| Blurred vision | 1 (0.8) | 1 (1.4) | 0 (0) | >.99 | 1 (0.8) | 1 (1.4) | 0 (0) | >.99 | |
| Skin rashes | 1 (0.8) | 0 (0) | 1 (2.0) | .87 | 0 (0) | 0 (0) | 0 (0) | N/A | |
| Infections | 5 (4.2) | 1 (1.4)c | 4 (8.0)d | .34 | 2 (1.6) | 2 (2.9)e | 0 (0) | >.99 | |
| Oxygen requirement | 3 (2.5) | 0 (0) | 3 (6.0) | .14 | 0 (0) | 0 (0) | 0 (0) | N/A | |
| Hospitalization | 7 (5.8) | 3 (4.3%) | 4 (8.0) | .65 | 4 (3.3) | 3 (4.3) | 1 (2.0) | .86 | |
| Able to workf | 10 (27.0) | 8 (33.3) | 2 (15.4) | .33 | 19 (51.4) | 13 (54.2) | 6 (46.2) | .57 | |
aICU: intensive care unit.
bN/A: not applicable.
cGastrointestinal infection.
d2 patients with lower respiratory tract infections and 2 patients with urinary tract infections.
e1 patient with lower respiratory tract infection and 1 patient with gastrointestinal infection.
fPercentages are based on responses from 37 patients who were employed, including 24 at 2-week follow-up and 13 at 6-week follow-up.